# TherapeuticsMD, Inc.: filings

TXMD · Nasdaq · CIK 25743 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/txmd.md) · [Financials](/companies/txmd/financials.md) · [Filings](/companies/txmd/filings.md) · [Insiders](/companies/txmd/insiders.md)

## Reports and events: 390 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 316, 8-K 248, 10-Q 53, SC 13G/A 46, 3 36, SC 13D 32, 10-K 18, UPLOAD 17, 424B5 14, 5 13, DEFA14A 13, DEF 14A 12, SC 13G 12, 8-K/A 10, CORRESP 10, SC 13D/A 10, 424B2 9, EFFECT 8, 424B3 7, 10-K/A 6, D 6, S-8 6, CT ORDER 5, PRE 14A 5, 4/A 4, ARS 4, POS AM 4, S-3 4, SEC STAFF LETTER 4, 3/A 3, DEF 14C 3, NT 10-K 3, PRE 14C 3, PRER14C 3, SC 14D9/A 3, SC TO-T/A 3, 424B7 2, 8-A12B 2, FWP 2, POSASR 2, S-3ASR 2, SCHEDULE 13G 2, SC TO-I/A 2, 144 1, 25 1, AW 1, CERTNAS 1, CERTNYS 1, NT 10-Q 1, PRER14A 1, S-1 1, S-3MEF 1, S-8 POS 1, SC 14D9 1, SC14D9C 1, SCHEDULE 13G/A 1, SC TO-C 1, SC TO-I 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:05 ET | [10-Q](/filings/0001213900-26-087768.md) | Quarterly report, period 2026-06-30 | 0001213900-26-087768 |
| 2026-08-11 | 16:00 ET | [8-K](/filings/0001213900-26-087756.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-087756 |
| 2026-05-12 | 16:16 ET | [10-Q](/filings/0001213900-26-055081.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055081 |
| 2026-05-12 | 16:10 ET | [8-K](/filings/0001213900-26-055070.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-055070 |
| 2026-04-01 | 21:53 ET | [10-K/A](/filings/0001213900-26-037918.md) | Annual report, amended, period 2025-12-31 | 0001213900-26-037918 |
| 2026-03-30 | 17:56 ET | [8-K](/filings/0001213900-26-036519.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-036519 |
| 2026-03-30 | 17:43 ET | [10-K](/filings/0001213900-26-036515.md) | Annual report, period 2025-12-31 | 0001213900-26-036515 |
| 2026-01-21 | 17:43 ET | [8-K](/filings/0001213900-26-005779.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-005779 |
| 2025-12-16 | 16:01 ET | [8-K](/filings/0001213900-25-122240.md) | 5.07 Shareholder vote results | 0001213900-25-122240 |
| 2025-11-13 | 20:54 ET | [8-K](/filings/0001213900-25-109479.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-109479 |
| 2025-11-12 | 17:27 ET | [10-Q](/filings/0001213900-25-109381.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109381 |
| 2025-11-03 | 16:02 ET | [DEF 14A](/filings/0001213900-25-105183.md) | Proxy statement, period 2025-12-15 | 0001213900-25-105183 |
| 2025-08-12 | 16:34 ET | [10-Q](/filings/0001213900-25-075003.md) | Quarterly report, period 2025-06-30 | 0001213900-25-075003 |
| 2025-08-12 | 16:16 ET | [8-K](/filings/0001213900-25-074975.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-074975 |
| 2025-05-13 | 16:37 ET | [10-Q](/filings/0001213900-25-042697.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042697 |
| 2025-05-13 | 16:15 ET | [8-K](/filings/0001213900-25-042663.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042663 |
| 2025-04-30 | 17:00 ET | [10-K/A](/filings/0001213900-25-037713.md) | Annual report, amended, period 2024-12-31 | 0001213900-25-037713 |
| 2025-04-09 | 06:30 ET | [8-K](/filings/0001213900-25-030089.md) | 8.01 Other events | 0001213900-25-030089 |
| 2025-03-27 | 16:50 ET | [10-K](/filings/0001013762-25-003442.md) | Annual report, period 2024-12-31 | 0001013762-25-003442 |
| 2025-03-27 | 16:30 ET | [8-K](/filings/0001013762-25-003407.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-25-003407 |
| 2024-12-05 | 17:15 ET | [8-K](/filings/0001213900-24-106095.md) | 5.07 Shareholder vote results | 0001213900-24-106095 |
| 2024-11-12 | 16:16 ET | [10-Q](/filings/0001213900-24-096811.md) | Quarterly report, period 2024-09-30 | 0001213900-24-096811 |
| 2024-11-12 | 16:15 ET | [8-K](/filings/0001213900-24-096804.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-096804 |
| 2024-10-25 | 17:00 ET | [DEF 14A](/filings/0001213900-24-090849.md) | Proxy statement, period 2024-12-05 | 0001213900-24-090849 |
| 2024-09-20 | 17:00 ET | [8-K](/filings/0001213900-24-080719.md) | 5.08 Item not in the standard list | 0001213900-24-080719 |
| 2024-08-12 | 17:16 ET | [10-Q](/filings/0001213900-24-067771.md) | Quarterly report, period 2024-06-30 | 0001213900-24-067771 |
| 2024-08-12 | 16:10 ET | [8-K](/filings/0001213900-24-067670.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-067670 |
| 2024-05-10 | 16:18 ET | [10-Q](/filings/0001213900-24-041738.md) | Quarterly report, period 2024-03-31 | 0001213900-24-041738 |
| 2024-05-10 | 16:15 ET | [8-K](/filings/0001213900-24-041735.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-041735 |
| 2024-04-29 | 17:00 ET | [10-K/A](/filings/0001213900-24-037258.md) | Annual report, amended, period 2023-12-31 | 0001213900-24-037258 |
| 2024-03-29 | 16:32 ET | [10-K](/filings/0001213900-24-028003.md) | Annual report, period 2023-12-31 | 0001213900-24-028003 |
| 2024-03-29 | 16:29 ET | [8-K](/filings/0001213900-24-027998.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-027998 |
| 2023-11-17 | 09:28 ET | [SC 13D/A](/filings/0001104659-23-119332.md) | Ownership report, active investor, amended | 0001104659-23-119332 |
| 2023-11-14 | 16:31 ET | [10-Q](/filings/0001193125-23-277143.md) | Quarterly report, period 2023-09-30 | 0001193125-23-277143 |
| 2023-11-14 | 16:25 ET | [8-K](/filings/0001193125-23-277136.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-277136 |
| 2023-08-18 | 17:18 ET | [8-K](/filings/0001193125-23-216056.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0001193125-23-216056 |
| 2023-08-14 | 07:30 ET | [10-Q](/filings/0001193125-23-211458.md) | Quarterly report, period 2023-06-30 | 0001193125-23-211458 |
| 2023-08-14 | 07:15 ET | [8-K](/filings/0001193125-23-211446.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-211446 |
| 2023-07-10 | 17:20 ET | [8-K](/filings/0001193125-23-184765.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-23-184765 |
| 2023-07-06 | 16:38 ET | [8-K](/filings/0001193125-23-182808.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-182808 |
| 2023-06-30 | 08:29 ET | [SC 13D/A](/filings/0001104659-23-076713.md) | Ownership report, active investor, amended | 0001104659-23-076713 |
| 2023-06-28 | 07:00 ET | [8-K](/filings/0001193125-23-176709.md) | 5.07 Shareholder vote results | 0001193125-23-176709 |
| 2023-05-17 | 17:01 ET | [DEF 14A](/filings/0001193125-23-147098.md) | Proxy statement, period 2023-06-26 | 0001193125-23-147098 |
| 2023-05-15 | 16:24 ET | [10-Q](/filings/0001193125-23-145064.md) | Quarterly report, period 2023-03-31 | 0001193125-23-145064 |
| 2023-05-15 | 16:16 ET | [8-K](/filings/0001193125-23-145019.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-145019 |
| 2023-05-05 | 17:26 ET | [8-K](/filings/0001193125-23-137263.md) | 1.01 Entry into a material agreement | 0001193125-23-137263 |
| 2023-05-01 | 17:03 ET | [10-K/A](/filings/0001193125-23-130656.md) | Annual report, amended, period 2022-12-31 | 0001193125-23-130656 |
| 2023-04-21 | 17:14 ET | [8-K](/filings/0001193125-23-110686.md) | 8.01 Other events | 0001193125-23-110686 |
| 2023-04-07 | 16:46 ET | [10-K](/filings/0001564590-23-005514.md) | Annual report, period 2022-12-31 | 0001564590-23-005514 |
| 2023-04-07 | 16:41 ET | [8-K](/filings/0001193125-23-095317.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-095317 |

Page 1 of 8. [Older](/companies/txmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:52 ET. No prices; not investment advice.